News

New Partnership Announcement: CMN x EDUGENE

We’re excited to announce a strategic partnership between CRISPR Medicine News (CMN) and EDUGENE - coming together to advance CRISPR and biotechnology education across Africa.

- Aug. 5, 2025
News

New Partnership Announcement: CRISPR Medicine News x EDUGENE

CRISPR Medicine News (CMN) is excited to announce a strategic partnership between CMN and EDUGENE - coming together to advance CRISPR and biotechnology education across Africa.

Through this collaboration, CMN plan to:

  • Share curated CRISPR content tailored for students and educators
  • Support virtual internships and mentorship opportunities
  • Co-host student innovation challenges - with the winner invited to the CRISPRMED26 Conference in Copenhagen, April 13-16, 2026
  • Launch joint webinars, guest lectures, and highlight important news from the CRISPR field

Together, CMN and EDUGENE are laying the groundwork for a stronger, more connected biotech education ecosystem in Africa.

Stay tuned for more updates coming later in 2025.

Tags

HashtagArticleHashtagNewsHashtagSTEMAFRICAHashtagEDUGENE

CLINICAL TRIALS
Type 1 Primary Hyperoxaluria, PH1, (NCT06892301)
Sponsors:
Guangzhou Women and Children's Medical Center
Indicator
IND Enabling
Phase I
Phase II
Phase III
End-Stage Renal Disease, (NCT07053462)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine